Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $21.7B
- 77 holdings
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
AUM over time
Book
| RVMD, Revolution Medicines | Reduce −0.3% | 14,582,796 | $79.65 | $1.2B | −42,896 | +$479M | |
| MSFT, Microsoft | Add +15.7% | 2,214,079 | $483.62 | $1.1B | +300,944 | +$80M | |
| AMZN, Amazon | Add +28.4% | 4,499,894 | $230.82 | $1B | +994,194 | +$269M | |
| AON, Aon | Add +17.0% | 2,665,238 | $352.88 | $941M | +387,221 | +$128M | |
| NTRA, Natera | Reduce −8.0% | 3,914,366 | $229.09 | $897M | −339,086 | +$212M | |
| BSX, Boston Scientific | Add +56.7% | 7,439,564 | $95.35 | $709M | +2,693,007 | +$246M | |
| EXEL, Exelixis | Reduce −19.4% | 15,709,500 | $43.83 | $689M | −3,792,000 | −$117M | |
| BBIO, Bridgebio | Add +9.8% | 8,998,463 | $76.49 | $688M | +806,463 | +$263M | |
| PTGX, Protagonist Therapeutics | Reduce −0.8% | 6,144,006 | $87.34 | $537M | −52,000 | +$125M | |
| WAB, Wabtec | Add +12.3% | 2,476,003 | $213.45 | $529M | +270,905 | +$86M | |
| UNH, UnitedHealth Group | Reduce −15.2% | 1,598,906 | $330.11 | $528M | −287,594 | −$124M | |
| Cyberark Software | New | 1,053,040 | $446.06 | $470M | +1,053,040 | +$470M | |
| DIS, Disney | Reduce −20.6% | 4,125,991 | $113.77 | $469M | −1,072,977 | −$126M | |
| SNPS, Synopsys | New | 999,200 | $469.72 | $469M | +999,200 | +$469M | |
| TMO, Thermo Fisher Scientific | Reduce −49.5% | 635,685 | $579.45 | $368M | −622,556 | −$242M | |
| LNTH, Lantheus | Add +56.1% | 5,427,479 | $66.55 | $361M | +1,950,252 | +$183M | |
| ARMK, Aramark | Add +4.0% | 9,357,046 | $36.86 | $345M | +360,844 | −$553K | |
| CRM, Salesforce | Reduce −48.8% | 1,261,177 | $264.91 | $334M | −1,201,133 | −$249M | |
| SCHW, Charles Schwab | Add +2.7% | 3,339,657 | $99.91 | $334M | +88,000 | +$23M | |
| CRNX | Add +20.2% | 6,933,098 | $46.55 | $323M | +1,163,000 | +$82M | |
| AVGO, Broadcom | New | 892,400 | $346.10 | $309M | +892,400 | +$309M | |
| LQDA, Liquidia | Add +1.1% | 8,656,038 | $34.49 | $299M | +90,400 | +$104M | |
| NDAQ, Nasdaq | Reduce −17.5% | 2,989,213 | $97.13 | $290M | −633,830 | −$30M | |
| BEAM, Beam Therapeutics | Hold | 10,063,111 | $27.72 | $279M | — | — | |
| KKR | New | 2,017,700 | $127.48 | $257M | +2,017,700 | +$257M | |
| GOOG, Alphabet | Reduce −29.8% | 787,040 | $313.80 | $247M | −333,900 | −$26M | |
| MCK, McKesson | Reduce −8.6% | 298,900 | $820.29 | $245M | −28,200 | −$7.5M | |
| V, Visa | Add +16.0% | 695,910 | $350.71 | $244M | +96,100 | +$39M | |
| NYT, New York Times | Reduce −34.2% | 3,280,678 | $69.42 | $228M | −1,705,067 | −$58M | |
| DAY, Dayforce | New | 2,925,000 | $69.16 | $202M | +2,925,000 | +$202M | |
| GRAL, Grail | Add +73.7% | 2,342,684 | $85.59 | $201M | +993,684 | +$121M | |
| BITW, Bitwise 10 Crypto Index ETF | New | 3,385,500 | $58.76 | $199M | +3,385,500 | +$199M | |
| CBRE, CBRE Group | Reduce −39.1% | 983,771 | $160.79 | $158M | −632,267 | −$96M | |
| AGIO, Agios Pharmaceuticals | Reduce −10.8% | 5,159,505 | $27.22 | $140M | −621,561 | −$92M | |
| CNTA, Centessa Pharmaceuticals | Add +24.1% | 5,377,068 | $25.01 | $134M | +1,045,750 | +$29M | |
| BBNX, Beta Bionics | Hold | 4,313,920 | $30.47 | $131M | — | — | |
| CAH, Cardinal Health | Add +127.7% | 576,000 | $205.50 | $118M | +323,000 | +$79M | |
| TNGX, Tango Therapeutics | Add +21.4% | 13,061,411 | $8.86 | $116M | +2,304,411 | +$25M | |
| HIMS, Hims & Hers Health | Reduce −68.5% | 3,386,986 | $32.47 | $110M | −7,359,866 | −$500M | |
| GBTC, iShares Bitcoin Trust ETF | Reduce −69.4% | 2,137,100 | $49.65 | $106M | −4,855,600 | −$348M | |
| MA, Mastercard | Reduce −19.2% | 172,671 | $570.88 | $99M | −41,100 | −$23M | |
| CDTX, Cidara Therapeutics | Reduce −24.6% | 382,800 | $220.89 | $85M | −125,200 | +$36M | |
| THC, Tenet Healthcare | Reduce −10.1% | 372,153 | $198.72 | $74M | −41,847 | −$10M | |
| WELL, Welltower | New | 343,000 | $185.61 | $64M | +343,000 | +$64M | |
| TRU, Transunion | Reduce −85.7% | 675,000 | $85.75 | $58M | −4,057,075 | −$339M | |
| TYRA, Tyra Biosciences | Add +80.7% | 2,066,818 | $26.29 | $54M | +923,000 | +$38M | |
| VNET, Vnet Group | Add +14.5% | 6,285,386 | $8.46 | $53M | +796,266 | −$3.5M | |
| ABVX, Abivax | Reduce −51.9% | 387,000 | $134.86 | $52M | −418,000 | −$16M | |
| ENTA, Enanta Pharmaceuticals | Add +30.6% | 2,772,262 | $15.77 | $44M | +650,000 | +$18M | |
| ASMB, Assembly Biosciences | Hold | 1,227,590 | $34.01 | $42M | — | — | |
| BIDU, Baidu | Add +51.6% | 315,300 | $130.66 | $41M | +107,304 | +$14M | |
| JOYY | Reduce −7.5% | 578,200 | $64.76 | $37M | −46,800 | +$813K | |
| ETHA, iShares Ethereum Trust | Reduce −80.1% | 1,481,001 | $22.43 | $33M | −5,969,729 | −$202M | |
| GPCR, Structure Therapeutics | New | 454,000 | $69.55 | $32M | +454,000 | +$32M | |
| MLYS, Mineralys Therapeutics | Reduce −50.8% | 823,296 | $36.29 | $30M | −849,757 | −$34M | |
| SUN, Sunococorp | New | 606,277 | $49.28 | $30M | +606,277 | +$30M | |
| PCSC, Perceptive Cap Solutions | New | 2,250,000 | $13.03 | $29M | +2,250,000 | +$29M | |
| TERN, Terns Pharmaceuticals | New | 642,000 | $40.40 | $26M | +642,000 | +$26M | |
| EHC, Encompass Health | Reduce −58.9% | 234,500 | $106.14 | $25M | −336,500 | −$48M | |
| AMKR, Amkor Technology | New | 464,000 | $39.48 | $18M | +464,000 | +$18M | |
| VSTM, Verastem | New | 2,000,000 | $7.72 | $15M | +2,000,000 | +$15M | |
| DOCS, Doximity | Reduce −16.8% | 311,000 | $44.28 | $14M | −63,000 | −$14M | |
| GH, Guardant Health | Add +1262.5% | 109,000 | $102.14 | $11M | +101,000 | +$11M | |
| MDLN, Medline | New | 260,000 | $42.00 | $11M | +260,000 | +$11M | |
| EDU | Reduce −65.3% | 196,000 | $55.03 | $11M | −369,150 | −$19M | |
| NERV, Minerva Neurosciences | New | 2,365,000 | $4.02 | $9.5M | +2,365,000 | +$9.5M | |
| WGS, Genedx | Add +1300.0% | 70,000 | $130.06 | $9.1M | +65,000 | +$8.6M | |
| ETH | New | 228,340 | $28.06 | $6.4M | +228,340 | +$6.4M | |
| PRME, Prime Medicine | Reduce −73.9% | 1,240,843 | $3.47 | $4.3M | −3,509,157 | −$22M | |
| OSCR, Oscar Health | Reduce −92.7% | 264,000 | $14.37 | $3.8M | −3,375,000 | −$65M | |
| MDGL, Madrigal Pharmaceuticals | Hold | 3,319 | $582.34 | $1.9M | — | — | |
| SMC, Summit Midstream | Hold | 58,214 | $26.68 | $1.6M | — | — | |
| NVAX, Novavax | Reduce −75.0% | 195,000 | $6.72 | $1.3M | −585,000 | −$5.5M | |
| SDGR, Schrodinger | Reduce −75.0% | 71,000 | $17.88 | $1.3M | −213,000 | −$4.4M | |
| TEVA, Teva Pharmaceutical Industries | Reduce −99.2% | 40,000 | $31.21 | $1.2M | −4,957,000 | −$100M | |
| CAPR | Hold | 41,000 | $28.86 | $1.2M | — | — | |
| ARWR, Arrowhead Pharmaceuticals | Hold | 15,800 | $66.39 | $1M | — | — | |
| ALVO, Alvotech | Hold | 199,675 | $5.13 | $1M | — | — | |
| BTSG, Brightspring Health Services | Hold | 22,000 | $37.45 | $824K | — | — | |
| ROIV, Roivant Sciences | Hold | 37,000 | $21.70 | $803K | — | — | |
| ARQT, Arcutis Biotherapeutics | Hold | 26,000 | $29.04 | $755K | — | — | |
| AXSM, Axsome Therapeutics | Hold | 4,000 | $182.64 | $731K | — | — | |
| COGT, Cogent Biosciences | Hold | 17,000 | $35.52 | $604K | — | — | |
| ALKS, Alkermes | Hold | 20,800 | $27.98 | $582K | — | — | |
| INSM, Insmed | Hold | 3,000 | $174.04 | $522K | — | — | |
| KRYS, Krystal Biotech | Hold | 2,000 | $246.54 | $493K | — | — | |
| PGNY, Progyny | Hold | 18,000 | $25.68 | $462K | — | — | |
| TVTX, Travere Therapeutics | Hold | 12,000 | $38.21 | $459K | — | — | |
| HQY, Healthequity | Hold | 5,000 | $91.61 | $458K | — | — | |
| IONS, Ionis Pharmaceuticals | Hold | 4,800 | $79.11 | $380K | — | — | |
| LIVN, Livanova | Hold | 6,000 | $61.53 | $369K | — | — | |
| GMED, Globus Medical | Hold | 4,000 | $87.31 | $349K | — | — | |
| COR, Cencora | Hold | 1,000 | $337.75 | $338K | — | — | |
| QURE, Uniqure | Reduce −97.5% | 14,000 | $23.93 | $335K | −551,000 | −$33M | |
| ONC, Beone Medicines | Hold | 1,100 | $303.81 | $334K | — | — | |
| CGON, CG Oncology | Hold | 8,000 | $41.52 | $332K | — | — | |
| SRRK, Scholar Rock | Hold | 7,000 | $44.05 | $308K | — | — | |
| IMVT, Immunovant | Hold | 12,000 | $25.42 | $305K | — | — | |
| NUVL, Nuvalent | Hold | 3,000 | $100.59 | $302K | — | — | |
| ASND, Ascendis Pharma A/s | Hold | 1,400 | $213.24 | $299K | — | — | |
| VCYT, Veracyte | Hold | 7,000 | $42.10 | $295K | — | — | |
| GKOS, Glaukos | Hold | 2,600 | $112.91 | $294K | — | — | |
| SBRA, Sabra Health Care REIT | Hold | 14,000 | $18.94 | $265K | — | — | |
| MMSI, Merit Medical Systems | Hold | 3,000 | $88.14 | $264K | — | — | |
| GRFS, Grifols | Hold | 28,000 | $9.35 | $262K | — | — | |
| ACLX, Arcellx | Hold | 4,000 | $65.20 | $261K | — | — | |
| URGN, Urogen | Hold | 11,000 | $23.42 | $258K | — | — | |
| PACB | Hold | 135,000 | $1.87 | $252K | — | — | |
| GEHC, GE HealthCare | Hold | 3,000 | $82.02 | $246K | — | — | |
| TWST, Twist Bioscience | Hold | 7,650 | $31.72 | $243K | — | — | |
| MIRM, Mirum Pharmaceuticals | Hold | 3,000 | $78.99 | $237K | — | — | |
| SLNO, Soleno Therapeutics | Reduce −96.7% | 5,000 | $46.30 | $232K | −148,000 | −$10M | |
| FOLD, Amicus | Hold | 16,000 | $14.24 | $228K | — | — | |
| ANNA, Aleanna | Hold | 78,400 | $2.85 | $223K | — | — | |
| ICLR, Icon | Hold | 1,200 | $182.22 | $219K | — | — | |
| SNDX, Syndax Pharmaceuticals | Hold | 10,000 | $21.01 | $210K | — | — | |
| HR, Healthcare Realty Trust | Hold | 12,000 | $16.95 | $203K | — | — | |
| DYN, Dyne Therapeutics | Hold | 10,000 | $19.56 | $196K | — | — | |
| BCRX, Biocryst Pharmaceuticals | Hold | 24,000 | $7.80 | $187K | — | — | |
| TVRD, Tvardi Therapeutics | Hold | 43,225 | $4.30 | $186K | — | — | |
| ARDX, Ardelyx | Hold | 23,000 | $5.83 | $134K | — | — | |
| ALT, Altimmune | Hold | 27,600 | $3.61 | $100K | — | — | |
| IOVA, Iovance Biotherapeutics | Hold | 26,000 | $2.73 | $71K | — | — | |
| GERN, Geron | Hold | 43,000 | $1.32 | $57K | — | — | |
| EVH, Evolent Health | Hold | 14,000 | $4.00 | $56K | — | — | |
| CCCC, C4 Therapeutics | Hold | 28,000 | $1.91 | $53K | — | — | |
| IRWD, Ironwood Pharmaceuticals | Hold | 13,000 | $3.37 | $44K | — | — | |
| CGC, Canopy Growth | Hold | 30,000 | $1.14 | $34K | — | — |
Showing top 50 of 128 by value
Exits / last held
Gone since 2025 Q3, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| ADSK, Autodesk | Exit | 0 | $317.67 | $528M | −1,662,852 | −$528M | |
| INTU, Intuit | Exit | 0 | $682.91 | $333M | −488,088 | −$333M | |
| K, Kellanova | Exit | 0 | $82.02 | $323M | −3,943,853 | −$323M | |
| ADI, Analog Devices | Exit | 0 | $245.70 | $319M | −1,299,500 | −$319M | |
| NSC, Norfolk Southern | Exit | 0 | $300.41 | $185M | −615,000 | −$185M | |
| IQV, IQVIA | Exit | 0 | $189.94 | $178M | −938,551 | −$178M | |
| WWD, Woodward | Exit | 0 | $252.71 | $157M | −621,973 | −$157M | |
| Mara | Exit | 0 | $18.26 | $67M | −3,660,000 | −$67M | |
| Grayscale Coindesk Crypto | Exit | 0 | $55.90 | $48M | −851,193 | −$48M | |
| Mr Cooper Group | Exit | 0 | $210.79 | $47M | −222,000 | −$47M | |
| NKTR, Nektar Therapeutics | Exit | 0 | $56.90 | $45M | −791,000 | −$45M | |
| FLUT, Flutter Entertainment | Exit | 0 | $254.00 | $35M | −137,369 | −$35M | |
| WAY, Waystar | Exit | 0 | $37.92 | $28M | −750,000 | −$28M | |
| SGRY, Surgery Partners | Exit | 0 | $21.64 | $19M | −871,830 | −$19M | |
| INTC, Intellia Therapeutics | Exit | 0 | $17.27 | $10M | −607,200 | −$10M | |
| TECX, Tectonic Therapeutic | Exit | 0 | $15.69 | $10M | −640,000 | −$10M | |
| Savara | Exit | 0 | $3.57 | $8.9M | −2,500,000 | −$8.9M | |
| iShares Trust | Exit | 0 | $271.12 | $5.1M | −18,907 | −$5.1M | |
| Allete | Exit | 0 | $66.40 | $5M | −75,000 | −$5M | |
| Merus | Exit | 0 | $94.00 | $282K | −3,000 | −$282K | |
| RARE | Exit | 0 | $30.14 | $211K | −7,000 | −$211K | |
| Beyond Meat | Exit | 0 | $1.89 | $36K | −19,000 | −$36K |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
Farallon Capital Management, L.l.c.
87 processed 13Fs on this site, 2021 Q3 to 2026 Q2